Turn Therapeutics Inc. Common Stock

Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates

Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group

Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs

Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences

Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference